NCT06735755: A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Disease Type Ia (GSDIa)
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 36 planned
- Started
- 6 Dec 2024
- Primary completion
- 30 Dec 2027
- Arms
- BEAM-301
- Results
- None posted
- 6 Dec 2024: Trial started
- 16 Dec 2024: Trial registered